doxorubicin actavis infusioonilahuse kontsentraat
actavis group ptc ehf. - doksorubitsiin - infusioonilahuse kontsentraat - 2mg 1ml 50ml 1tk; 2mg 1ml 25ml 1tk; 2mg 1ml 75ml 1tk; 2mg 1ml 100ml 1tk; 2mg 1ml 10ml 10tk; 2mg 1ml 5ml 10tk
doxorubicin teva infusioonilahuse kontsentraat
teva pharma b.v. - doksorubitsiin - infusioonilahuse kontsentraat - 2mg 1ml 100ml 1tk; 2mg 1ml 5ml 1tk; 2mg 1ml 10ml 1tk
doxorubicin actavis süstelahuse pulber
actavis group ptc ehf. - doksorubitsiin - süstelahuse pulber - 10mg 1tk
doxorubicin actavis süstelahuse pulber
actavis group ptc ehf. - doksorubitsiin - süstelahuse pulber - 50mg 1tk
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubitsiini vesinikkloriid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastilised ained - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
doxorubicin-teva infusioonilahuse kontsentraadi pulber
pharmachemie b.v. - doksorubitsiin - infusioonilahuse kontsentraadi pulber - 50mg 1tk
daunoxome infusioonilahuse kontsentraat
almac pharma services limited - daunorubitsiin - infusioonilahuse kontsentraat - 2mg 1ml 25ml 1tk
cerubidine infusioonilahuse pulber
cenexi-laboratoires thissen sa - daunorubitsiin - infusioonilahuse pulber - 20mg 1tk
daunosin süstelahuse pulber ja lahusti
kocak farma ilac ve kimya sanayi a.s. - daunorubitsiin - süstelahuse pulber ja lahusti - 20mg 1tk
daunoblastin süstelahuse pulber ja lahusti
actavis italy s.p.a. - daunorubitsiin - süstelahuse pulber ja lahusti - 20mg 1tk